Skip to main content
Clinical Trials/JPRN-UMIN000051013
JPRN-UMIN000051013
Recruiting
N/A

Study on evaluation and prediction of dry skin, peripheral neuropathy, and hyperglycemia due to administration of enfortumab vedotin - Study on evaluation and prediction of dry skin, peripheral neuropathy, and hyperglycemia due to administration of enfortumab vedotin

niversity of Shizuoka0 sites40 target enrollmentMay 9, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Shizuoka
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 9, 2023
End Date
March 31, 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Shizuoka

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Patients with a history of drug hypersensitivity that may interfere with this treatment. 2\.Patients with uncontrolled serious complications. 3\.Patients who are pregnant or may be pregnant. 4\.Others deemed inappropriate by the attending physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials